Subtopic Deep Dive
ABCA1 in Reverse Cholesterol Transport
Research Guide
What is ABCA1 in Reverse Cholesterol Transport?
ABCA1 (ATP-binding cassette transporter A1) mediates the initial step of reverse cholesterol transport by facilitating cellular cholesterol efflux to lipid-poor apoA-I, forming nascent HDL particles.
ABCA1 dysfunction causes Tangier disease, characterized by low HDL and macrophage foam cell accumulation (Dean et al., 2001, 1732 citations). Nuclear receptors LXR and PPAR regulate ABCA1 expression to control cholesterol homeostasis (Costet et al., 2000, 971 citations; Chinetti et al., 2001, 1159 citations). Over 10 key papers from 2000-2014 detail its mechanisms, with Glass and Witztum (2001, 3030 citations) linking it to atherosclerosis.
Why It Matters
ABCA1 drives cholesterol removal from macrophages, preventing foam cell formation in plaques (Glass and Witztum, 2001). PPAR activators stimulate ABCA1 to enhance efflux from human foam cells, offering therapeutic potential for atherosclerosis (Chinetti et al., 2001). LXR agonists upregulate ABCA1 via sterol-dependent transactivation, targeting low HDL syndromes (Costet et al., 2000). These mechanisms inform drugs for cardiovascular disease linked to diabetic dyslipidemia (Taskinen, 2003).
Key Research Challenges
Tangier Disease Mutations
Mutations in ABCA1 cause cholesterol accumulation and low HDL in Tangier disease (Dean et al., 2001). Identifying functional impacts of specific variants remains challenging. Genetic variation effects on transporter activity need precise mapping (Dean et al., 2001, 1278 citations).
Regulatory Phosphorylation Mechanisms
Phosphorylation controls ABCA1 trafficking and efflux efficiency to apoA-I. Dissecting kinase pathways and lipidation steps requires advanced cellular models (Schultz et al., 2000). LXR integration adds complexity to signaling (Zelcer, 2006).
Macrophage Foam Cell Formation
ABCA1 deficiency accelerates foam cell development in plaques (Glass and Witztum, 2001). Quantifying efflux rates under inflammatory conditions is difficult. PPAR/LXR crosstalk needs better elucidation for drug targeting (Chinetti et al., 2001).
Essential Papers
Atherosclerosis
Christopher K. Glass, Joseph L. Witztum · 2001 · Cell · 3.0K citations
The Human ATP-Binding Cassette (ABC) Transporter Superfamily
Michael Dean, Andrey Rzhetsky, Rando Allikmets · 2001 · Genome Research · 1.7K citations
The ATP-binding cassette (ABC) transporter superfamily contains membrane proteins that translocate a variety of substrates across extra- and intra-cellular membranes. Genetic variation in these gen...
Role of LXRs in control of lipogenesis
Joshua R. Schultz, Hua Tu, Alvin Luk et al. · 2000 · Genes & Development · 1.7K citations
The discovery of oxysterols as the endogenous liver X receptor (LXR) ligands and subsequent gene targeting studies in mice provided strong evidence that LXR plays a central role in cholesterol meta...
PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway
Giulia Chinetti, Sophie Lestavel, Virginie Bocher et al. · 2001 · Nature Medicine · 1.2K citations
Sterol-dependent Transactivation of theABC1 Promoter by the Liver X Receptor/Retinoid X Receptor
Philippe Costet, Yi Luo, Nan Wang et al. · 2000 · Journal of Biological Chemistry · 971 citations
Tangier disease, a condition characterized by low levels of high density lipoprotein and cholesterol accumulation in macrophages, is caused by mutations in the ATP-binding cassette transporter ABC1...
Liver X receptors as integrators of metabolic and inflammatory signaling
Noam Zelcer · 2006 · Journal of Clinical Investigation · 943 citations
The liver X receptors (LXRs) are nuclear receptors that play central roles in the transcriptional control of lipid metabolism. LXRs function as nuclear cholesterol sensors that are activated in res...
Cholesterol Efflux and Atheroprotection
Robert S. Rosenson, H. Bryan Brewer, W. Sean Davidson et al. · 2012 · Circulation · 923 citations
Reading Guide
Foundational Papers
Start with Glass and Witztum (2001, 3030 citations) for ABCA1-atherosclerosis links, then Dean et al. (2001, 1732 citations) for ABC transporter genetics in Tangier disease, followed by Chinetti et al. (2001, 1159 citations) for PPAR-ABCA1 efflux mechanisms.
Recent Advances
Study Zelcer (2006, 943 citations) for LXR inflammatory integration; Rosenson et al. (2012, 923 citations) for atheroprotective efflux; Li and Chiang (2014, 873 citations) for bile acid signaling overlaps.
Core Methods
Efflux assays to apoA-I quantify ABCA1 activity; LXR/PPAR agonist treatments test regulation; genetic knockout models reveal Tangier phenotypes (Costet et al., 2000; Chinetti et al., 2001).
How PapersFlow Helps You Research ABCA1 in Reverse Cholesterol Transport
Discover & Search
Research Agent uses searchPapers and citationGraph to map ABCA1-LXR regulation from Costet et al. (2000), revealing 971 citing papers on sterol transactivation. exaSearch finds Tangier disease variants; findSimilarPapers expands from Dean et al. (2001) to related ABC transporters.
Analyze & Verify
Analysis Agent applies readPaperContent to extract ABCA1 efflux data from Chinetti et al. (2001), then verifyResponse with CoVe checks claims against Glass and Witztum (2001). runPythonAnalysis processes citation networks with pandas for LXR-ABCA1 co-citation trends; GRADE scores evidence strength for Tangier mutations.
Synthesize & Write
Synthesis Agent detects gaps in macrophage foam cell regulation post-2001 papers, flagging underexplored phosphorylation. Writing Agent uses latexEditText and latexSyncCitations to draft reviews citing Dean et al. (2001), with latexCompile for figures and exportMermaid for LXR-PPAR signaling diagrams.
Use Cases
"Analyze cholesterol efflux rates from ABCA1 knockout data in macrophages"
Research Agent → searchPapers('ABCA1 macrophage efflux') → Analysis Agent → runPythonAnalysis (pandas on efflux datasets from Chinetti et al. 2001) → matplotlib plots of rate comparisons.
"Write LaTeX review on ABCA1 regulation by LXR in Tangier disease"
Synthesis Agent → gap detection (Costet et al. 2000) → Writing Agent → latexEditText (draft section) → latexSyncCitations (Dean et al. 2001) → latexCompile (full PDF with HDL diagrams).
"Find code for ABCA1 simulation models from recent papers"
Research Agent → paperExtractUrls (Glass and Witztum 2001 supplements) → paperFindGithubRepo → githubRepoInspect → exportCsv of simulation scripts for efflux modeling.
Automated Workflows
Deep Research workflow scans 50+ ABCA1 papers via citationGraph from Dean et al. (2001), generating structured reports on Tangier mutations with GRADE grading. DeepScan applies 7-step CoVe to verify LXR-ABCA1 links in Chinetti et al. (2001), checkpointing foam cell data. Theorizer builds hypotheses on PPAR phosphorylation regulation from Schultz et al. (2000).
Frequently Asked Questions
What defines ABCA1's role in reverse cholesterol transport?
ABCA1 exports cholesterol to lipid-poor apoA-I, initiating HDL formation and preventing macrophage foam cells (Costet et al., 2000).
What are key methods to study ABCA1 function?
Cellular efflux assays measure cholesterol release to apoA-I; LXR/PPAR agonists test regulation in foam cells (Chinetti et al., 2001).
What are the most cited papers on ABCA1?
Glass and Witztum (2001, 3030 citations) on atherosclerosis; Dean et al. (2001, 1732 citations) on ABC superfamily including ABCA1 Tangier mutations.
What open problems exist in ABCA1 research?
Mapping mutation-specific efflux defects in Tangier disease; elucidating phosphorylation sites for apoA-I lipidation (Dean et al., 2001; Zelcer, 2006).
Research Cholesterol and Lipid Metabolism with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching ABCA1 in Reverse Cholesterol Transport with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers
Part of the Cholesterol and Lipid Metabolism Research Guide